Zum Inhalt

Annals of Hematology

Ausgabe 2/2026

Inhalt (37 Artikel)

Low serum albumin levels and the nongerminal center B-cell subtype according to the Hans algorithm as strong prognostic factors in ≥ 80-year-old patients with large B-cell lymphoma treated with rituximab-containing chemotherapy

  • Open Access
  • Research

Ichiro Kawashima, Ayato Nakadate, Hideto Hyuga, Minori Matsuura, Yuma Sakamoto, Jun Suzuki, Takuma Kumagai, Megumi Suzuki, Megumi Yamanda-Koshiishi, Takeo Yamamoto, Kei Nakajima, Naoki Oishi, Tetsuo Kondo, Keita Kirito

Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia

  • Open Access
  • Research

Keyue Hu, Yiquan Cheng, Gangfeng Xiao, Xiu Shen, Jingwen Zhu, Mengmeng Huang, Yang Fei, Suying Qian, Xiaona Shao

Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature

  • Open Access
  • Case Report

Silvio Rao, Arianna Liparoti, Juri Alessandro Giannotta, Andrea Artoni, Antonio Muscatello, Alessandra Bandera, Flora Peyvandi

Immune checkpoint inhibitor-induced pure red cell aplasia: a nationwide retrospective case series and literature review

  • Open Access
  • Correspondence

Sirivanh Bisiou, Hervé Lobbes, Pascale Palassin, Marion Allouchery, Thibault Comont, Valérian Rivet

Global burden of non-Hodgkin lymphoma in the elderly: a population-based study using GBD 2021

  • Open Access
  • Research

Yue Wang, Jie Chen, Jindou Guo, Yuqin Song, Jun Zhu, Jun Ma, Maigeng Zhou, Jinlei Qi, Weiping Liu

One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib

  • Open Access
  • Research

Lucía Pérez-Lamas, Mario Manzanares, Juan Carlos Hernández Boluda, Luis Felipe Casado Montero, María Teresa Gómez Casares, Rosa Ayala, Blanca Xicoy, Francisca Ferrer Marin, Guillermo Ortí, Raquel De Paz Arias, Santiago Osorio Prendes, Raul Perez Lopez, Elvira Mora, Concepción Ruiz Nuño, Antonio Jimenez Velasco, Concepción Boqué, Magdalena Sierra Pacho, Joaquin Martinez Lopez, Gonzalo Carreño-Tarragona, Mayte Coiras, Valentin Garcia-Gutierrez

Vascular complications in NPM1-Mutated acute myeloid leukemia: clinical features and prognosis

  • Open Access
  • Research

Xiaoying Wang, Wenbin Mo, Miao Chen, Jingchen Sui, Renjie Bian, Xiaojing Yan

KIT Mutant/Core binding factor-negative acute myeloid leukemia might be a complex subgroup with dismal prognosis: a single-center retrospective analysis

  • Open Access
  • Research

Rui Jiang, Zhibo Zhang, Yizi Liu, Wenqiang Qu, Zhao Zeng, Linlin Wang, Qian Wang, Jia Yin, Suning Chen

Blinatumomab exposure prior to allogeneic stem cell transplantation is associated with increased Epstein-Barr virus reactivation

  • Open Access
  • Research

Hai-Lu Sun, Zhi-Fan Zhao, Xian-Ying Yin, Meng Lv, Ling Ma, Fang-Fang Wei, Xiao-Su Zhao, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Xu-Ying Pei

TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma

  • Open Access
  • Research

Shuozi Liu, Shaowei Zhou, Weilong Zhang, Jing Wang, Lingli Wang, Chunyuan Li, Yingtong Chen, Wenxin Qi, Ping Yang, Hongmei Jing

Case series: a rare dominant form of β-thalassemia successfully treated by luspatercept

  • Open Access
  • Case Report

Pierre N. Allard, Andreas E. Kulozik, Joachim B. Kunz

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)

  • Open Access
  • Review

Nicola Giesen, Sibylle C. Mellinghoff, Elham Khatamzas, Felix Korell, Marcus Hentrich, Hermann Einsele, Larissa Henze, Claus Peter Heußel, Christian Hohmann, Björn-Erik Ole Jensen, Malte B. Monin, Philippe Schafhausen, Enrico Schalk, Karsten Spiekermann, Sebastian Voigt, Marie von Lilienfeld-Toal, Daniel Teschner, Oliver A. Cornely, Christina Rieger, Elena Busch

Assessment of long-read strategies for the enrichment of clinically relevant breakpoints in lymphomas: towards a diagnostic implementation

  • Open Access
  • Research

Filip Pardy, Kamila Reblova, Hana Svozilova, Boris Tichy, Sarka Pospisilova, Jana Kotaskova, Veronika Navrkalova

Classical Hodgkin lymphoma associated with immune deficiency and dysregulation exhibits a prognosis similar to sporadic cases but with distinct predictive markers

  • Open Access
  • Research

Junichi Mukae, Hiroki Akiyama, Keisuke Tanaka, Kota Yoshifuji, Ayako Nogami, Natsuka Umezawa, Yoshihiro Umezawa, Kouhei Yamamoto, Toshikage Nagao, Shinsuke Yasuda, Hirokazu Kanegane, Masatoshi Takagi, Takehiko Mori, Masahide Yamamoto

PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype

  • Open Access
  • Research

Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, Claudia D. Baldus, Hubert Serve, Carsten Müller-Tidow, Kerstin Schäfer-Eckart, Martin Kaufmann, Stefan W. Krause, Mathias Hänel, Andreas Neubauer, Gerhard Ehninger, Uwe Platzbecker, Martin Bornhäuser, Johannes Schetelig, Jan M. Middeke, Christian Thiede

Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study

  • Open Access
  • Research

Anna Paola Iori, Antonio De Vivo, Eros Di Bona, Giovanni Caocci, Francesca Fioritoni, Fabio Ciceri, Eloise Beggiato, Davide Rapezzi, Angela Amendola, Amalia Figuera, Carmine Selleri, Francesco Longu, Bruno Fattizzo, Alessandra Tucci, Alessandro Cignetti, Valeria Amico, Simona Sica, Elisabetta Metafuni, Simona Raso, Tiziana Anna Urbano, Luana Marano, Nicola Di Renzo, Pierangelo Spedini, Alessandro Rambaldi, Francesco Lanza, Cristina Clissa, Cristina Danesin, Maria Bruna Greve, Sergio Cabibbo, Alessandra Ori, Francesca Cassanelli, Federica Sottana, Benedetta Campolo, Giulia Gasparri, Fabio Carini, Wilma Barcellini

Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry

  • Open Access
  • Research

C. J. M. Halkes, E. A. S. Koster, E. J. M. Bogers, F. C. J. I. Heubel-Moenen, L. G. M. Daenen, S. K. Klein, S. M. C. Langemeijer, E. Nur, M. H. G. Raaijmakers, T. J. F. Snijders, J. M. L. Tjon, L. C. de Wreede

A meta-analysis of immunosuppressive and Pharmacological therapies in aplastic anaemia with and without Indigenous equine antithymocyte globulin (eATG)

  • Open Access
  • Review

Biju George, Cecil Reuben Ross, Sharat Damodar, Tulika Seth, Tuphan Kanti Dolai, Saswata Banerjee, Rajan Manguesh, Pankaj Malhotra

Acute psychosis following initiation of ruxolitinib in post-polycythaemia vera myelofibrosis case report

  • Open Access
  • Case Report

Louise Jade Potter, Sachin Shetty, M. Mansour Ceesay

GANT61 suppresses proliferation and induces apoptosis in ALK-Positive anaplastic large cell lymphoma via modulating the Hh-PIK3IP1-Akt signaling axis

  • Open Access
  • Research

Hongyuan Chen, Jingjing Gao, Chuntuan Li, Yan Han, Shengquan Liu, Xiongpeng Zhu

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

  • Open Access
  • Research

Yifen Lan, Yanchun Zhao, Jianai Sun, De Zhou, Jinghan Wang, Xiaolong Zheng, Yuanfei Shi, Haitao Meng, Juying Wei, Chunmei Yang, Wenjuan Yu, Jie Jin, Hongyan Tong, Wanzhuo Xie

Radiotherapy in addition to systemic therapy reduces the early mortality of angioimmunoblastic T-cell lymphoma

  • Open Access
  • Research

Yaobin Lin, Qiong Lin, Qizhen Xu, Shenghong Shi, Daxin Huang, Gaoda Ju, Shan Liu, Jianyuan Song, Qingliang Lin, Jianwu Chen

Diagnostic reassessment in myeloproliferative neoplasms: the value of functional iron parameters and JAK2 allelic burden

  • Open Access
  • Research

Rita González-Resina, Sara España-Fernández de Valderrama, Ángeles Montañés, Valle Recasens, Gonzalo Caballero

Risk factors for early mortality (within 6 weeks of diagnosis) in Chinese children with acute leukemia: a single-center retrospective cohort study

  • Open Access
  • Research

Li’an Du, Fu Li, Luping Ding, Li Song, Xiaoling Li, Muyuan Ji, Wenting Pei, Ruoying Wei, Zhijuan Liu, Hui Ding, Xiaomei Yang

Pulmonary thromboembolism in Glanzmann Thrombasthenia: a case report and systematic literature review

  • Open Access
  • Case Report

Tayebe Mohammad Alizade, Reihaneh Karimi, Hossein Kazemizadeh, Niloofar Khoshnam Rad

Audiological profile for assessment of sensorineural hearing loss in treatment naïve chronic myeloid leukemia: impact of early TKI treatment on reversibility

  • Open Access
  • Research

Harshal Mamlekar, Sanjeev Yadav, Ravi Sankar Manogaran, Rajesh Kashyap, Khaliqur Rahman, Ruchi Gupta, Dinesh Chandra, Manish Singh, Adya Parmar, Keerti Anand

TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study

  • Open Access
  • Research

Haiyan Zhang, Xiang Zhang, Jinghan Wang, Xuewu Zhang, Yunfei Lv, Yanan Zhu, Xingnong Ye, Juying Wei, Min Yang, Gaixiang Xu, Chunmei Yang, Haitao Meng, Wanzhuo Xie, Jie Jin, Hongyan Tong, Wenjuan Yu

Next-generation Bruton’s tyrosine kinase inhibitors for chronic lymphocytic leukemia-associated membranoproliferative glomerulonephritis: a case report

  • Open Access
  • Case Report

Li Chen, Yuting Huang, Jing Xu, Sinian Huang, Qianying Zhang, Fanli Hua, Xiaoxia Pan, Jian-Qing Mi

Hemophagocytic lymphohistiocytosis associated with extranodal NK/T cell lymphoma, nasal type or aggressive NK cell leukemia: a retrospective multicenter study of Jiangsu Cooperative Lymphoma Group (JCLG)

  • Open Access
  • Research

Yongle Li, Yanping Liu, Yilian Yang, Zihan Liang, Yi Xia, Ling Gao, Jingxin Zhou, Bingzong Li, Chunling Wang, Liang Yu, Miao Sun, Yuqing Miao, Haiwen Ni, Xiaoyan Xie, Yunping Zhang, Min Zhao, Guoqiang Lin, Tao Jia, Qiudan Shen, Lei Fan, Jianyong Li, Xuzhang Lu, Wenyu Shi, Yi Miao

Machine learning mortality prediction model for cyclosporine therapy in pediatric aplastic anemia

  • Open Access
  • Research

Xianhao Wen, Li Xiao, Danni Li, Meiling Liao, Yuye Liu, Qihui Liu, Xianmin Guan, Ying Dou, Ziyu Hua

Impact of marital status on survival in patients with follicular lymphoma

  • Open Access
  • Research

Songyuan He, Hao Song, Weiyi Zuo, Shu Liu, Xiaojie Fang, Xudong Li

Addition of rituximab to CEAC conditioning for autologous hematopoietic stem cell transplantation provides no survival benefit in diffuse large B-Cell lymphoma: A propensity score-matched cohort study

  • Open Access
  • Research

Chaoshuai Fan, Jiabang Yang, Yanni Peng, Juan Hu, Mingyue Cao, Ruobing Li, Dongmei Jiang, Tao Wang, Wen Luo, Li Chen, Yanrong Luo, Guihua Lu

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Podcast

„Für gute rheumatologische Diagnostik braucht es nicht viel“

Von Cortison über Biologika zu CAR‑T‑Zellen: Was ändert sich aktuell in der Rheumatologie? Prof. Elisabeth Märker-Hermann wirft gemeinsam mit Moderator Prof. Markus M. Lerch einen Blick auf die Behandlung von Polymyalgia rheumatica, rheumatoider Arthritis oder Lupus erythematodes. Einige Paradigmenwechsel sind hier im Gange. Die Rheumatologin betont außerdem: Einfache Fragen und wenige Basisuntersuchungen geben erste wichtige diagnostische Hinweise.

Deutsche Gesellschaft für Innere Medizin

Fokale Salvage-Therapie bei lokalem Prostatakrebsrezidiv langfristig wirksam

Bei einem nach Radiotherapie lokal rezidivierten Prostatakarzinom sind fokale Salvage-Therapien mit einer guten Prognose verbunden: Das krebsspezifische Zehn-Jahres-Überleben ist einem retrospektiven Vergleich zufolge ebenso hoch wie nach Salvage-Prostatektomie.

Relacorilant verlängert Überleben bei platinresistentem Ovarialkarzinom

Durch Hinzunahme des Glukokortikoid-Rezeptor-Antagonisten Relacorilant zu nab-Paclitaxel wird bei Frauen mit platinresistentem Ovarialkarzinom nicht nur das progressionsfreie, sondern auch das Gesamtüberleben verlängert. Laut finaler Analyse der ROSELLA-Studie gewinnen sie vier Monate an Lebenszeit.

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, DGIM Podcast-Reihe - Rheumatologie/© (M) Laura Dittmann (Symbolbild mit Fotomodell) Logo: Springer Medizin Verlag GmbH, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell)